KBLB Kraig Biocraft Laboratories Inc (QB)

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) is working on new medicines to advance the treatment of rare forms of chronic and acute leukemia, lung cancer and other rare cancers. The company has recently released data from is treatment trials. PharmaCyte Biotech, Inc. (OTCQB: PMCB) is closer to beginning a clinic trial in advanced, inoperable pancreatic cancer after the FDA granted its request for a pre-IND (Investigational New Drug) meeting. Anavex Life Sciences Corp. (NASDAQ: AVXL) lead drug candidate, ANAVEX 2-73, is currently in a Phase 2a clinical trial for Alzheimer’s disease. Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) is leading the development of genetically engineered spider silk based fiber technologies. The company has developed a new product with a strength expected to exceed its previous products.

Get the full analysis and todays tiny float feature profile here- Full Report
(Copy paste to browser may be required- https://secure.blueoctane.net/forms/TEOTA9ZE8XK5 )
 
 
FORWARD-LOOKING DISCLAIMER
 
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbour created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the subject company in this report to be materially different from the statements made herein.
 
 
COMPLIANCE PROCEDURE
 
Content is researched, written and reviewed on a best-effort basis. Information in this release is fact checked and produced on a best efforts basis. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. The subject Company has not compensated Traders News Source for the creation or dissemination of this report. Traders News Source is the party responsible for issuing the press release and for hosting the full analyst report on Traders News Source website.
 
NOT FINANCIAL ADVICE
 
Traders News Source makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
 
NO WARRANTY OR LIABILITY ASSUMED
 
Traders News Source is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Traders News Source whatsoever for any direct, indirect or consequential loss arising from the use of this document. Traders News Source expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Broad Street Alerts does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
 
 
Source: Traders News Source
Contact: editor@tradersnewssource.com